CompletedNot Applicable

Genetic Risk Assessment for Cancer Education and Empowerment (GRACE) Project

United States668 participantsStarted 2017-11-02

Plain-language summary

GRACE is a randomized 3-arm trial to determine the comparative effectiveness of two remote cancer communication interventions: 1) a targeted generic print (TP) or 2) a tailored telephone-based counseling and navigation intervention (TCN). Post-award, the target sample size was revised to (n=642) with NIH permission.

Who can participate

Age range

21 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Breast Cancer * Hispanic or non-Hispanic * Female * 21 years of age or older * English-speaking * Breast cancer history * breast cancer at the age of 50 or younger OR * triple-negative breast cancer OR * two or more primary breast cancers Ovarian Cancer * Hispanic or non-Hispanic * Female * 21 years of age or older * English-speaking * History of ovarian, fallopian, or peritoneal cancer diagnosed at any age Exclusion Criteria: Have had prior genetic counseling or testing for hereditary breast and/or ovarian cancer

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Medically Verified Cancer Genetic Risk Assessment Uptake at 6 Months

Timeframe: 6 months following the interventions for TP and TCN, and 6 months following the baseline survey for the UC arm.

Trial details

NCT IDNCT03326713

SponsorRutgers, The State University of New Jersey

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-06-02

Results submitted2025-04-21

View on ClinicalTrials.gov More Breast Cancer trials